NEUMOLOGÍA PEDIÁTRICA

C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl 316 Prevención y medidas de protección frente a la infección por SARS-CoV-2 Neumol Pediatr 2020; 15 (2): 308 - 316 REFERENCIAS 1. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang F, et al. “Epidemiology of COVID-19 among children in China”. Pediatr. (2020); 145(6):e20200702 2. Escuela de Salud Pública de la Universidad de Chile, Elementos para el abordaje a la epidemia COVID-19 en Chile, 20 de marzo de 2020. 3. Kilpatrick R & Meissner C. “What you need to know to reduce the risk of respiratory virus spread”. Am. Acad. Pediatri. 2020; https://www.aappublications.org/ news/2020/04/06/idsnapshot040620 4. Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan Y. et al. “Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”. Mil. Med. Res. 2020; 7:4. 5. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. N. Engl. J. Med. 2020; 382;8: 727-733 6. Department of Labor Occupational Safety and Health Administration OSHA 3990-03 2020, Guidance on Preparing Workplaces for COVID-19 U.S. 7. Tinku J & Mohammed A, International Pulmonologist´s, “Consensus on COVID-19”. https://www.unah.edu. hn/dmsdocument/9674-consenso-internacional-de- neumologos-sobre-covid-19-version-ingles 8. How COVID-19 Spreads https://www.cdc.gov/ coronavirus/2019-ncov/prevent-getting-sick/how-covid- spreads.html?CDC_AA_refVal=https%3A%2F%2Fwww. c d c . g o v % 2 F c o r o n a v i r u s % 2 F 2 0 1 9 - ncov%2Fprepare%2Ftransmission.html 9. Morawskaa L & Caob J. “Airborne transmission of SARS-CoV-2: The world should face the reality”. (2020). Environment. Int. 2020; 139 (2020) 105730. 10. National Institute of Health, NIH clinical trial of investigational vaccine for COVID-19 begins https://www. nih.gov/news-events/news-releases/nih-clinical-trial- investigational-vaccine-covid-19-begins 11. Lurie N, Saville M, Hatchett R, Halton J. “Developing Covid-19 Vaccines at Pandemic Speed”. N. Engl. J. Med. 2020. (Article in Press). https://www.nejm.org/doi/ full/10.1056/NEJMp2005630#article_citing_articles 12. Leo P & Malik P. “Emergence of a novel human coronavirus threatening human health”. Nature. 2020; 26:313-319. 13. World Health Organization, Considerations for quarantine of individuals in the context of coronavirus disease (COVID-19): Interim guidance, 14. Yang K, Wang L, Li F, Chen D, Li X, Qiu C, et al. “The influence of preventive strategies on COVID-2019 epidemic in Shenzhen, China”. Eur. Respir. J. 2020; (Article in press) https://doi.org/10.1183/13993003.00599-2020. 15. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. “Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts”. Brit. Med. J. Yale. 2020. (Article in Press). doi: https://doi. org/10.1101/2020.03.03.20028423 16. Kampf G , Todt D, Pfaender S, Steinmann E. “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents”. J. Hosp. Infect. 2020; 104: 246-251. 17. Van-Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B et al. “Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1” N. Engl. J. Med. 2020. (Article in press). doi: https://doi.org/1 0.1101/2020.03.09.20033217. 18. Kilpatrick R, & Meissner C. “How to reduce risk of COVID-19 transmission in outpatient settings, FAAP”. April 08, 2020 https://www.aappublications.org/news/2020/04/08/ idsnapshot040820?cct=2287 19. Pu Y, Zheng J, Chen F, Long Y, Wu H, Li Q, et al. “Preparation of Polypropylene Micro and Nanofibers by Electrostatic- Assisted Melt Blown and Their Application”. J. Polym. 2018; 10, 959. doi:10.3390/polym10090959. 20. Jeremy H, Huang A, Li Z, Tufekci Z, Zdimal V, Van der Westhuizen H, et al. “Face masks against COVID-19: An evidence review”. Preprints. 2020. (Article in press). doi:10.20944/preprints202004.0203.v1 21. 3M Science Applied to life. Comparison of FFP2, KN95, and N95 and Other Filtering Facepiece Respirator Classes. Technical Bulletin January, 2020 Revision 2. 22. 3M Science Applied to life. Respiratory Protection for Airborne Exposures to Biohazards. Technical Data Bulletin Release 4, April 2020 #174 23. Castañeda J & Hernández H, “Mascarilla N95: una medida útil en la prevención de la tuberculosis pulmonar”. Acta. Pediatr. Mex. 2017; 38(2):128-133. 24. Rengasamy S, King W, Eimer B, Shaffer R. “Filtration Performance of NIOSH-Approved N95 and P100 Filtering Facepiece Respirators Against 4 to 30 Nanometer-Size Nanoparticles”. J. Occup. Environ. Hyg.2008; 5: 556–564 25. Brainard J, Jones N, Lake L, Hooper L , Hunter P. “Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review”. Brit. Med. J. Yale. 2020. (Article in Press). doi: https://doi.org/ 10.1101/2020.04.01.20049528. 26. Ministerio de Salud de Chile, Subsecretaria de Redes Asistenciales, Circular C13 N° 09 del 13 de marzo de 2013, Precauciones estándares para el control de infecciones en la atención en salud y algunas consideraciones sobre aislamiento de pacientes. 27. Ministerio de Salud de Chile, Subsecretaria de Salud Pública, Reglamento sobre manejo de residuos de establecimientos de atención de salud (REAS), https:// www.leychile.cl/N?i=1008725&f=2017-03-10&p= 28. Ministerio de Salud de Chile, Subsecretaria de Redes Asistenciales, Circular C37 N° 01 del 18 de marzo de 2020, Protocolo de referencia para correcto uso de equipo de protección personal en pacientes sospechosos o confirmados de COVID-19. 29. Ministerio de Salud de Chile, Subsecretaria de Redes Asistenciales, Circular C37 N° 02 del 03 de abril de 2020, Racionalización del uso de equipos de protección personal (EPP) en el contexto de la atención de pacientes durante la pandemia de COVID-19. 30. Ministerio de Salud de Chile, https://www.minsal.cl/ wp-content/uploads/2020/04/Recomendaciones-de- actuacion-en-lugares-de-trabajo.pdf